chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8/16/04: 2-3 hours after vaccination. Bumps, hives, and axil. temp 102.3. 8/17/04: symptoms continued. 8/18/04: symptoms intensified: admitted to ER with hives, fever (105.1 pa per mom) about 3PM> examined, blood drawn, IV started, discharged 10 PM on ? amoxicillin. 0.04 ml TID. 8/19/04: per mom: alert, responsive, good appetite, to pediatrician today.
Patient received a flu shot and Pneumonia shot on 10-26-16. Presented to Pharmacy with red blotchy skin from the upper area to elbow in arm that she received vaccination. Headache, body ache.
c/o of left arm cramping and dizziness.  required a wheelchair. no meds for intervention needed.
had a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (had a sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 047B21A) for COVID-19 vaccination.     No medical history was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced VACCINATION SITE PAIN (had a sore arm). At the time of the report, VACCINATION SITE PAIN (had a sore arm) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No concomitant and treatment medication was reported   This case was linked to MOD-2021-168611 (Patient Link).
Got COVID -I felt extremely fatigue, with sinus, I developed a cold and a fever. I was weak. I slept 16 hours a day. The day before I lost my sense of taste. I developed numbness on my mouth. On my feet, hand and my face. And inside my mouth. I had to see a Neurologist.
11/09 at 8 Pm was clearing throat 11/10 clearing throat and mucousy cough 11/11 developed fever 102.4 axillary, runny nose, cough, congestion 11/12 fever to 103 chills, complained could not breathe, lethargic, no appetite 11/13 Taken to ER diagnosed with viral URI;  took to ED at 7 PM due to lethargy diagnosed with pneumonia, sent home on zithromax 11/14 taken back to ED with temp to 104, trouble breathing, did aerosal tx 11/15 last fever 101.8 As of 11/18 sx resolved except for cough, reevaluated 11/19 in family Practice
shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was unknown.  Company Comment: Based on the current available information and the temporal association between the product use and the start date of the event a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the event a causal relationship cannot be excluded.
first dose on 30-AUG-21, should receive second dose?; generalized itchy rash all over her body; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On 3rd September 2021, 4 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the patient experienced incomplete course of vaccination. The patient was treated with antihistamine (Antihistamines) and steroids nos (Steroids). On an unknown date, the outcome of the itchy rash was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received 1st dose of Shingrix vaccine and experienced generalized itchy rash all over her body. The patient was advised that 4 days after she developed a generalized itchy rash all over her body. The patient visited an urgent care where they prescribed antihistamines and a course of steroids. The rash went away after 5 days and was now resolved.  Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient wanted to know if she should receive second dose.   The patient was given medical advise disclaimer. Emergency room visit required. The patient gave permission to contact HCP(health care professional). The reporter consented to follow-up.
Wednesday my skin on the left side of my back got sensitive, on Friday I had a pain in my back, but I went on Saturday to the ER with extreme abdominal pain and in my back (that started on Friday) and then I had a rash on Sunday, a visible rash, on Monday I went to the doctor, and he verified that I had shingles.
Irritability Anxiety Depression Anger  Also, three weeks after taking the 2nd dose, I fell into a deep depression.
got sick the day after the vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got sick the day after the vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021296341 same reporter/drug/event, different patient
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 30-OCT-2012 the patient was vaccinated subcutaneously with a dose of ZOSTAVAX (Lot# and dose not reported). On 01-NOV-2012 the patient contacted the pharmacist for medical attention. On 01-NOV-2012 the patient had developed a red 3" welt in diameter at the injection site. There was no pain associated with the event. Patient's status was not reported. Additional information is not expected.
Mother called the morning after shots to report the child's face was swollen "just like it was when he was allergic to erythromycin".  Mother gave liquid Benadryl and was told to take to ER.  Mother took child to PMD instead and he told her to keep giving Benadryl.
fever; aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (aches) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), MYALGIA (aches) and HEADACHE (headache). At the time of the report, PYREXIA (fever), MYALGIA (aches) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were provided
Redness/swelling on upper arm, pain in shoulder when moving the arm, area is hot to touch, advised ibuprofen, cold compress, return to office if any open sores, oozing, weeping, or fever.
It was reported that a patient received a TD Adult vaccination, date not specified. Reportedly sometime after the vaccination the patient developed "flu-like" symptoms and a local reaction, red swollen arm. Further information is requested.
Information has been received from a health professional concerning a patient who was vaccinated (date unknown) with varicella virus vaccine live. It was noted that 12-Apr-2003 the patient's 7 month-old younger brother who had not been vaccinated because of his age came down with the chicken pox. Subsequently two weeks later, reported as 26-Apr-2003, the patient who had been vaccinated, "broke out with a moderate case of chicken pox". Unspecified medical attention was sought. The reporter mentioned that two other siblings also "broke out with moderate cases of chicken pox" following vaccination with varicella virus vaccine live (WAES #0304USA01423), (WAES#0305USA00437). Additional information has been requested.
Child was accidently administer the whole undiluted vial of Covid Pfizer 6 mos to 4 year vaccine dose.
THE PATIENT RECEIVED THE MODERNA VACCINE AND AT HER AGE OF 12 SHE SHOULD NOT HAVE. THE PATIENT DID NOT HAVE ANY ADVERSE EVENTS OTHER THAN THE USUAL SORE ARM. THE PATIENT THEN RECEIVED THE SECOND SHOT ON 9-3-21 OF THE MODERNA VACCINE. THE PATIENT'S MOTHER WAS NOTIFIED AND WAS NOT CONCERNED.
Patient received their first Moderna COVID vaccine on 4.13.2021. Patient states that immediately after getting the COVID vaccine he felt the "medicine go from his shoulder to his leg." Patient waited the 15 minute waiting period and "felt weird" but states that he did not tell any staff members because he thought it may be anxiety. Patient then describes driving. Patient was contacted by his wife numerous times and she reports that he was disoriented and very confused. Patient drove himself from Emergency Department in. Patient's wife states that he was diagnosed with altered mental status and had elevated cardiac enzymes. Patient was admitted to the floor for one night for observation. Patient was recommended to have a stress test upon hospital discharge. As of 4.16.21, patient feels back to normal, plans to schedule cardiac stress test through primary care.
Pt. passed out when sent to waiting area to wait 15 minutes. Gave alcohol swab to sniff on. Also asked if had something to eat. Per pt had only breakfast. Offered juice and crackers. Pt. also mentioned being scared of needles.
NOT ADVERSE EVENT; Patient was given the correct vaccine NDC lot number FT1551 -- however box of previous lot number was scanned instead lot number FL2757 with expiration date of 9/30/22
Patient and mom walked out of exam room to head into room across hall where Sib was. Patient fainted and  fell backward hitting the back of his head on the floor, where he then went into a seizure like state. Non responsive, arms and legs stiffened and started to thrash. Then lost bladder control. Started to come to approx a minute-2 minutes after event, where he started crying for his mom, and also asking what had happened. PCP was present the entire time and kept him down due to head injury trying to keep him from moving his head. Patient c/o head hurting but was aware of surroundings.
Personality changes; headaches; extreme fatigue; Also, I was unaware on conversations that I had.; I had high blood pressure and insomnia.; I had high blood pressure and insomnia.; It would seem that I had cerebritis from the shot; This is a spontaneous report from a contactable physician (patient). A 42-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EL1284, expiry date not reported), via an unspecified route of administration, administered in right arm (at the age of 42 years old) on 08Jan2021 14:30 as a single dose for covid-19 immunisation. There were no medical history (reported as none) and no concomitant medications. The patient had no known allergies. The patient had no covid prior vaccination. The patient received the first dose of bnt162b2 (brand as Pfizer) for Covid-19 immunisation on 18Dec2020 (at the age of 42 years old) at 03:30 PM administered on the right arm. The vaccine was administered on a hospital. The patient had no other vaccine in four weeks and no other medications in two weeks. On 08Jan2021 11:00 PM, the patient experienced personality changes, headaches, and extreme fatigue, and also was unaware on conversations that he had. The symptoms lasted about 24 hours acutely, but for the 3 weeks afterwards, patient had high blood pressure and insomnia (2021). It would seem that patient had cerebritis from the shot since an unspecified date in 2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit. There were no treatments received in response to the events reported. The patient was not tested for COVID post vaccination. The outcome of the events was recovered with lasting effects.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment. Based on the available clinical data, the event encephalitis most likely represented an intercurrent medical condition not related to vaccination with BNT162B2. This case will be re-assessed when relevant follow-up information is received.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Pain in injected arm and light headache starting 3-4 hours later. The next day I woke up with low blood pressure, dizziness, mild headache, mild fatigue and a low fever. It subsided with ibuprofen. 2 days later my armpit on same side of injection was mildly painful with movement and quite swollen.  3rd day my armpit remains equally or more swollen. Mild fatigue.
She has large lymph node swelling of the L axilla, side of her vaccine, softball sized.  limited ROM of the arm, still swollen 3 weeks later
Menstrual cycle 15 days later; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 14Apr2021 at 12:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks of vaccination. The patient's menstrual cycle started on 04Apr2021, her cycle was regular for every 24 to 28 days. On 19Apr2021 at 10:00, the patient got her menstrual cycle 15 days later, that was not normal. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle 15 days later was unknown at the time of this report.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Suspected Myocarditis - chest pains, heart palpitations, chest tightness Skin hives/rashes
Within two days after receiving the vaccine, I developed a raised pink spot at the injection spot which lasted about a week. I used cortisone cream and BENADRYL spray it helped to relieve my symptoms. I did not see a doctor and self-treated.
On 10/10/2019 I was administered a influenza vaccine into my Left deltoid at approximately 2:40pm. The vaccine was Given with my shirt collar pulled down off my shoulder and was very high up on my arm. It hurt when I got it. A bandaid was placed and I left. Upon trying to close my car door my arm was very painful. I went home and removed the bandaid to find the bloody spot from the injection was about and inch to and inch and a half higher than the bandaid. Later I tried to go to the gym and found I couldn't lift weights. A thick band of tissue running from my shoulder down vertically through my deltoid was in a big lump and making noises when I moved my arm. My shoulder only wanted to move in certain directions. I went home and took Aleve assuming the pain would subside. Every week afterwards it was getting worse and I lost range of motion which was painful to move in certain directions and do simple tasks. On 11/27/19 I returned to Health Care to be evaluated for shoulder pain due to a flu shot. The doctor stated she doubted it was from my flu shot and that it wouldn't hurt me six weeks plus later. She sent me for X-rays and I was referred to an orthopedist. I was evaluated given a cortisone injection, told I got tendonitis/bursitis, and also told if the injection and physical therapy didn't fix it I would likely need surgery to clean it out. I have seen Physical therapy for six weeks as of now and still have limited range of motion mobility with my Left arm, pain, nausea, and my arm feels like its going to pop out of the socket. I have been given two Ionto pain patches at PT and have been Kinesiology taped. I have two more visits and then to be re-evaluated at PT to make 8 weeks I have requested a referral to the orthopedist/shoulder specialist. I am a dental hygienist and this has affected my ability to work more days than I am currently working due to pain and limited motion. I also had an MRI done on 12/31/2019 which showed inflammation and fluid in the muscle, as well as a possible labral tear. I am currently still in treatment with no resolution. I Have inquired if ligaments or tendons were hit during the injection only to not be given a straight answer. I still can not go to the gym and use my upper body due to this issue.
pt recv vax & over the next 2 days pt devel muscle weakness & dimpling @ the site of inj;5 days p/vax an area of muscle @ the inj site, measuring 3" long by 1/2" deep, was noted to be wasting & atrophied;
Pt recvd vax 13MAY92 & on 24MAY92 pt's mom stated pt could not bend knee; On 27MAY92 pt was seen by MD who noted that pt could bend knee; 3JUN92 pt was re-checked by another MD who noted that the sx was resolving but that will revax w/HIB;
Top of arm at shoulder is red, hard and tender to touch or sleep on; Top of arm at shoulder is red, hard and tender to touch or sleep on; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Top of arm at shoulder is red, hard and tender to touch or sleep on) and MUSCULOSKELETAL DISCOMFORT (Top of arm at shoulder is red, hard and tender to touch or sleep on) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Top of arm at shoulder is red, hard and tender to touch or sleep on) and MUSCULOSKELETAL DISCOMFORT (Top of arm at shoulder is red, hard and tender to touch or sleep on). At the time of the report, ERYTHEMA (Top of arm at shoulder is red, hard and tender to touch or sleep on) and MUSCULOSKELETAL DISCOMFORT (Top of arm at shoulder is red, hard and tender to touch or sleep on) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Patient had received Moderna booster 2 days ago.   Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2023: Live follow-up received contains updated reporter details, patient initials and reference ID.
on trip w/daycare immed p/vax mom did not give APAP or protect child from heat;about 3hr later started having abd pain, vomiting next, face & lips  white, lips cold, lifeless, eyes rolling back in head, problems breathing & coryza;
Pt recvd vax & exp burning immediately upon administration of 1st dose of Engerix-B;
vial was stored in the refrigeration; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (vial was stored in the refrigeration) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was stored in the refrigeration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (vial was stored in the refrigeration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient received booster dose. The vial was placed in the refrigerator on 29-Oct-2021. Vial did not undergone any temperature excursion. No adverse event was reported. No treatment medications were reported.
High fever 103 sustained Dizziness Chills Diarrhea Vomiting Extreme lethargy
Severe diarrhea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Severe diarrhea) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Severe diarrhea). At the time of the report, DIARRHOEA (Severe diarrhea) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.    This case was linked to MOD-2021-076873, MOD-2021-042580, MOD-2021-040930, MOD-2021-107944 (E2B Linked Report).; Sender's Comments:  MOD-2021-076873:Same reporter/different patient (wife 1st dose) MOD-2021-042580:Same reporter/different patient (wife 2nd dose) MOD-2021-040930:Same reporter/different patient (husband) MOD-2021-107944:Same reporter/different patient (80s male)
2-17-12 Client return for reading of TB skin test with mother. Mother reported that he had a reaction from the "chicken pox" vaccine. Child's left arm at the varicella injection site was red and raised 3 1/2" x 3 1/2", in the center a heart like shape appeared a darker red. Mother reported the evening after the vaccine his arm appeared to have a blister and was warm to touch. Child reports that it is not painful and "it itches".